Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Chemical Test Refined to Detect Tainted Heparin

By LabMedica International staff writers
Posted on 11 Oct 2011
A rapid test has been devised that will detect adulterated heparin, a blood thinner taken by millions of people worldwide each year to prevent blood clots.

The test can quickly and economically detect adulterants, including the substance responsible for hundreds of illnesses and deaths among patients taking heparin in 2008 that had to be recalled. More...


Scientists from the US Food and Drug Administration (Silver Spring, MD, USA) identified the culprit, a substance called over-sulfated chondroitin sulfate (OSCS). They developed a 96-well plate format assay for sensitive detection of OSCS in heparin active pharmaceutical ingredient (API) and crude heparin based on Leclerc polythiophene polymer (LPTP) and heparinase digestion of heparin. OSCS is a synthetic dietary supplement derived from chondroitin sulfate type A that some people take to treat osteoarthritis. Scientists concluded that OSCS, which is inexpensive, had been intentionally added to heparin as a so-called “economically motivated adulterant” (EMA), to boost profits. Current tests to detect EMAs in heparin are difficult to perform and must be done in laboratories.

To overcome these challenges, the investigators developed a simple color test in which normal heparin samples turn red in color, but OSCS contaminated samples do not change color. In the present study, they wanted to know whether their test could detect additional EMAs. They found that the test could detect several other possible EMAs, such as those that could be made by over-sulfation of waste products formed during heparin production. The colorimetric microplate LPTP/heparinase test detected OSCS in heparin sodium API by the naked eye down to the 0.1% level and in crude heparin down to the 0.1% level with a plate reader.

The investigators concluded on the basis of their results, a portable test to detect even tiny amounts of different EMAs could be developed to insure the safety of the heparin supply chain. Like heparin, OSCS also prevents blood from forming dangerous clots, but unlike heparin, OSCS can trigger potentially fatal anaphylactic reactions in sensitive individuals. The study was published on August 5, 2011, in the journal Analytical Chemistry.

Related Links:

US Food and Drug Administration



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.